Cardiovascular health remains a global concern, and one of the reasons that consumers seek protective benefits of dietary supplementation. As much as 80% of consumers in Europe and the US recognize the link between good heart health and good overall health (FMCG).
In recent years, there has been a strong focus on the role of arterial stiffness impacting cardiovascular health, as well as the discovery of the vitamin K-dependent protein Matrix Gla Protein (MGP).
MGP is the most potent modulator of vascular calcification known, provided the body has enough Vitamin K2 to activate it.
MenaQ7® is the only clinically proven Vitamin K2 as MK7 for cardiovascular health with groundbreaking studies. The 3-year study showed a nutritional dose of MenaQ7® taken daily not only inhibited age-related arterial stiffening, but also promoted vascular elasticity.
Choose MenaQ7® to support your heart health claims with science!
Latest news & videos
- News
- Quatrefolic®
- Wellness & Immune
- Jun 12, 2025
Webinar Rethinking Women’s Health 24 June 2025
Women's health is complex, constantly evolving, and a broader perspective is long overdue, one...
- News
- Quatrefolic®
- Wellness & Immune
- Jun 09, 2025
Gnosis by Lesaffre Highlights Quatrefolic® at New Nutrition Forum in Hangzhou, China
Gnosis by Lesaffre was proud to serve as the Title Sponsor of the New...
- Corporate
- Digestion & Gut
- News
- Jun 06, 2025
Biotic Live: A Successful First Edition Exploring the Power of Probiotic Yeasts
Gnosis by Lesaffre recently hosted the first edition of Biotic Live, a unique event...
